Dokter Lies Knippenberg
ActiveDokter Lies Knippenberg has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €88k and a net result of €104k. Equity is growing by ~21.8% per year across the filed fiscal years. Its solvency ranks better than 20% of 16424 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2025
76
/ 100
Excellent
The score weighs solvency, liquidity and profitability. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability98▲+2
Solvency45▼-55
Growth68▲+16
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €6k at 30 days acceptable
Liquidity tight (current ratio 1.24 against 74.32 in 2024; short-term debt: 80% and cash: 92.1% of total assets), and 80% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Seven signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
20%
Return on assets
23.6%
Age of the figures
9 mo
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 16424 sector peers (2025).
NBB · sector comparisonPosition among 16424 sector peers
Solvency
better than 20%
← weakest
strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-03-2026, 122 days ahead of the deadline.
NBB · 6 filingsDeviation from the deadline
2025
122 d early
2024
14 d early
2023
44 d early
2022
30 d early
2021
26 d early
2020
9 d early
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
17-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€88k▼ 73.6%
2024 · €335k
2020: €88k
2021: €175k
2022: €252k
2023: €260k
2024: €335k
2020 → 2025
Total assets
€442k▲ 30.4%
2024 · €339k
2020: €149k
2021: €214k
2022: €283k
2023: €274k
2024: €339k
2020 → 2025
Net result
€104k▲ 39.7%
2024 · €75k
2020: €83k
2021: €87k
2022: €77k
2023: €56k
2024: €75k
2020 → 2025
Working capital
€86k▼ 74.1%
2024 · €333k
2020: €89k
2021: €178k
2022: €243k
2023: €255k
2024: €333k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€175k-€252k▲ 43.7%€260k▲ 3.2%€335k▲ 28.7%€88k▼ 73.6%
Operating result€111k-€97k▼ 12.4%€71k▼ 27.1%€91k▲ 28.6%€132k▲ 45.2%
Net result€87k-€77k▼ 12.1%€56k▼ 27.3%€75k▲ 33.9%€104k▲ 39.7%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
After the dip in 2023 the operating result has climbed two years in a row; 2025 is 45% above 2024 and is the highest result in the available series.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €442k
Fixed assets
€2k▼ 4.3%
Current assets
€440k▲ 30.6%
Equity and liabilities €442k
Equity
€88k▼ 73.6%
Debt
€354k▲ 7,704%
The debt ratio rises from 1.3% to 80.0%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€133k▲
2024 · €96k
Cash flow
€105k▲
2024 · €80k
Solvency
20.0%▼
2024 · 98.7%
Current ratio
1.24▼
2024 · 74.32
Quick ratio
1.24▼
2024 · 74.32
Debt / equity
4.01▲
2024 · 0.01
ROE
118.1%▲
2024 · 22.3%
ROA
23.6%▲
2024 · 22.0%
Interest coverage
289.43▼
2024 · 354.16
Debt
€354k▲
2024 · €5k
Debt ≤ 1 year
€354k▲
2024 · €5k
Income taxes
€30k▲
2024 · €20k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€339k€442k▲
Fixed assets21/28€2k€2k▼
Tangible fixed assets22/27€2k€2k▼
Plant, machinery and equipment23-€1k
Furniture and vehicles24€2k€746▼
Financial fixed assets28€250€250=
Current assets29/58€337k€440k▲
Amounts receivable within one year40/41€7k€2k▼
Trade receivables40€64€128▲
Other amounts receivable41€7k€2k▼
Current investments50/53€100k€0▼
Cash at bank and in hand54/58€189k€407k▲
Deferred charges and accrued income490/1€41k€31k▼
Equity and liabilities
Total equity and liabilities10/49€339k€442k▲
Equity10/15€335k€88k▼
Contributions10/11€5k€5k=
Reserves13€330k€83k▼
Distributable reserves133€330k€83k▼
Profit (loss) carried forward14€0€0=
Amounts payable17/49€5k€354k▲
Amounts payable after more than one year17€0-
Financial debts170/4€0-
Amounts payable within one year42/48€5k€354k▲
Current portion of amounts payable after more than one year42€2k€0▼
Trade debts44€679€673▼
Suppliers440/4€679€673▼
Taxes, remuneration and social security45€2k€3k▲
Taxes450/3€2k€3k▲
Other amounts payable47/48€0€351k▲
Income statement
Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€5k€1k▼
Other operating charges640/8€602€550▼
Gross operating margin9900€97k€134k▲
Operating profit (loss)9901€91k€132k▲
Financial income75/76B€3k€3k▼
Recurring financial income75€3k€3k▼
Financial charges65/66B€272€461▲
Recurring financial charges65€272€461▲
Profit (loss) for the period before taxes9903€94k€135k▲
Income taxes67/77€20k€30k▲
Profit (loss) for the period9904€75k€104k▲
Profit (loss) for the period to be appropriated9905€75k€104k▲
Appropriation of the result
Profit (loss) to be appropriated9906€75k€104k▲
Transfer from equity791/2€0€246k▲
Transfer to equity691/2€75k€0▼
To other reserves6921€75k€0▼
Profit to be distributed694/7€0€351k▲
Return on contributions (dividend)694€0€351k▲
The notes to these accounts (10 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-03
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema
2025
31-12
Financial
Highest result since 2020net €104k ▲39.7%
Operating result €132k, net result €104k, both a record.
17-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Liquidity triplescurrent ratio 74.32
Current ratio from 23.61 to 74.32; short-term debt falls from €11k to €5k.
17-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €56k ▼27.3%
Net result drops to €56k, the lowest in the series; recovery starts the following year.
31-12
Financial
Liquidity doublescurrent ratio 23.61
Current ratio from 10.60 to 23.61; short-term debt falls from €25k to €11k.
01-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Equity above €200kEq €252k ▲43.7%
3 profitable years in a row build equity to €252k.
05-07
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Liquidity triplescurrent ratio 10.04
Current ratio from 3.41 to 10.04; short-term debt falls from €37k to €20k.
31-12
Financial
Equity above €150kEq €175k ▲98.7%
2 profitable years in a row build equity to €175k.
22-07
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Maaseik · 1 establishment unit since 2020
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kapelweg 223680 MaaseikGround area
1,223 m²
Building footprint
229 m²
Volume, LiDAR
1,192 m³
Parcel 72021D0505/00N003, Flanders · tallest building 10.4 m, ±2 floors. Linked by address, not a title deed.
1 establishment unit
Dokter Lies Knippenberg
since 20202.305.726.127
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 72021D0505/00N003 | Flanders | 1,223 m² | 1 · 229 m² | 10.4 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Recognitions · licences · registrations
Legal Entity Identifier
984500QCC36E5C108823
Similar companies · same sector, comparable size
Dr Britt Nobus
BE 0765.524.196
Hove · Eq €88k
Dr. Sam Delvaux
BE 0773.946.667
Leuven · Eq €88k
Dr. Cis Nicasy
BE 0737.569.390
Geel · Eq €88k
Dr. Pauline Van den Bossche
BE 1014.597.234
Waasmunster · Eq €88k
VanCor Huisartsen
BE 0741.417.619
Heusden-Zolder · Eq €88k
Of 9,118 companies in sector 86210 we hold annual accounts for 6,336. 5,187 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded12-08-2020
Fiscal year end31-12
Abbreviation NL
Dr. Lies Knippenberg of Lies Knippenberg
Activities, NACEBEL
86210General medical practice
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Data from official sources, last processed on 16-09-2026. Scores and ratios are computed by Checked and are not a credit decision.